Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Novel acyclic nucleotide phosphonates against RNA viruses

Includes bibliographical references.

Saved in:
Bibliographic Details
Main Author: Bowden, Gregory David
Other Authors: Hunter, Roger
Format: Thesis
Language:English
Published: Department of Chemistry 2014
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613205457534976
access_status_str Open Access
author Bowden, Gregory David
author2 Hunter, Roger
author_browse Bowden, Gregory David
Hunter, Roger
author_facet Hunter, Roger
Bowden, Gregory David
author_sort Bowden, Gregory David
collection Thesis
description Includes bibliographical references.
format Thesis
id oai:open.uct.ac.za:11427/10258
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:32:26.116Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2014
publishDateRange 2014
publishDateSort 2014
publisher Department of Chemistry
publisherStr Department of Chemistry
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/10258 Novel acyclic nucleotide phosphonates against RNA viruses Bowden, Gregory David Hunter, Roger Chemistry Includes bibliographical references. Acyclic nucleotide phosphonates (ANPs) have been used for years as successful anti-viral agents against diseases such as HIV/AIDS and hepatitis while the drug ribavirin is one of the only drugs available for the treatment of RNA-viral infections which mainly affect the developing world. The large and unmet need for anti-RNA viral treatments has prompted this study into the design and synthesis of a range of ANPs, which includes a series of ribavirin-based ANP derivatives. The series of compounds was synthesised from a diisopropyl protected phosphonomethoxyethyl (PME) synthon and included an arylethynyltriazole derivative which was produced via a Sonogashira palladium catalysed cross-coupling reaction. A selection of these compounds was then deprotected to their corresponding phosphonic acids via a bromotrimethylsilane mediated phosphonate ester hydrolysis. In one example, a bis(pivaloyloxymethyl) prodrug variant was produced in order to probe a general synthesis for prodrug protected ANP derivatives. All new compounds were characterised by NMR, IR, and Mass spectroscopic techniques. 2014-12-27T14:16:33Z 2014-12-27T14:16:33Z 2012 Master Thesis Masters MSc http://hdl.handle.net/11427/10258 eng application/pdf Department of Chemistry Faculty of Science University of Cape Town
spellingShingle Chemistry
Bowden, Gregory David
Novel acyclic nucleotide phosphonates against RNA viruses
thesis_degree_str Master's
title Novel acyclic nucleotide phosphonates against RNA viruses
title_full Novel acyclic nucleotide phosphonates against RNA viruses
title_fullStr Novel acyclic nucleotide phosphonates against RNA viruses
title_full_unstemmed Novel acyclic nucleotide phosphonates against RNA viruses
title_short Novel acyclic nucleotide phosphonates against RNA viruses
title_sort novel acyclic nucleotide phosphonates against rna viruses
topic Chemistry
url http://hdl.handle.net/11427/10258
work_keys_str_mv AT bowdengregorydavid novelacyclicnucleotidephosphonatesagainstrnaviruses